FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study
Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might p...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21 April 2021
|
| In: |
European archives of psychiatry and clinical neuroscience
Year: 2021, Volume: 271, Issue: 5, Pages: 915-927 |
| ISSN: | 1433-8491 |
| DOI: | 10.1007/s00406-021-01259-7 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00406-021-01259-7 |
| Author Notes: | Patrick Bach, Georg Weil, Enrico Pompili, Sabine Hoffmann, Derik Hermann, Sabine Vollstädt-Klein, Falk Kiefer, Karl Mann, Wolfgang H. Sommer |
| Summary: | Pharmacological treatment in alcohol use disorder suffers from modest effect sizes. Efforts have been undertaken to identify patient characteristics that help to select individuals that benefit from pharmacological treatment. Previous studies indicated that neural alcohol cue-reactivity (CR) might provide a marker that identifies patients, which benefit from naltrexone treatment. |
|---|---|
| Item Description: | Published online: 21 April 2021 Gesehen am 05.12.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1433-8491 |
| DOI: | 10.1007/s00406-021-01259-7 |